Response to R. Jayaraj

Etienne Dauzier; Benjamin Lacas; Pierre Blanchard; Anne Aupérin; Jean-Pierre Pignon

doi:10.1016/j.oraloncology.2019.104439

Response to R. Jayaraj

Oral Oncol. 2020 Mar:102:104439. doi: 10.1016/j.oraloncology.2019.104439. Epub 2019 Nov 2.

Authors

Etienne Dauzier¹, Benjamin Lacas², Pierre Blanchard³, Anne Aupérin², Jean-Pierre Pignon²

Affiliations

¹ Meta-Analysis Unit, Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. Electronic address: dauzier.etienne@gmail.com.
² Meta-Analysis Unit, Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
³ Meta-Analysis Unit, Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France; Department of Radiation Therapy, Gustave Roussy Cancer Campus, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

PMID: 31685291
DOI: 10.1016/j.oraloncology.2019.104439

No abstract available

Keywords: Chemotherapy; Head and neck cancer; Heterogeneity; Individual patient data; Meta-analysis; Randomized trial; Squamous cell carcinoma; Surgery.

Publication types

Letter
Comment

MeSH terms

Head and Neck Neoplasms*
Humans
Squamous Cell Carcinoma of Head and Neck*